Date Published
November 2013

Page Count 
96

Additional Info 
Single-site, country, and global licenses are multi-user, searchable, and cut-and-paste ready PDFs delivered by e-mail.


 

For Global Licenses, Multi-Reports Orders, Discounts or Order Questions.

Contact:
Jeffrey Knight
Account Executive
781.247.6264

For Report Questions:

Contact:
Dan Miller
Marketing Associate
781-972-5492

 


IPR Bundle


Epigenetics: Emerging Targets, Available Technologies, Expert Interviews, and an Epigenetic Community Perspective - Overview

[ektdesignns_placeholder_ID0EP] 

Epigenetics: Emerging Targets, Available Technologies, Expert Interviews, and an Epigenetic Community Perspective  

Newly published from Insight Pharma Reports, Epigenetics: Emerging Targets, Available Technologies, Expert Interviews, and an Epigenetic Community Perspective, covers several technologies, epigenetic targets, and market outlook. The first part of this report covers necessary background information, mostly pertaining to epigenetic targets, and the reasons they are being investigated. Several companies have kindly disclosed several strategies, methods, and techniques that they use for either target identification or technology development.

 

Report Features Include:  

 

  • Insight Pharma Reports polled a survey which had more than 150 responses. Specific areas highlighted are targets under investigation, market outlook, and how partnerships with external organizations have advanced the industry
  • Interviews with CEOs, CSOs, and Expert Scientists from Constellation Pharmaceuticals, Epizyme Inc., and EpiTherapeutics, Active Motif, Cayman Chemical, and Reaction Biology
  • Company background information
  • Specific pharmaceutical/biopharmaceutical companies and their strategies